Logo image of CRL

CHARLES RIVER LABORATORIES (CRL) Stock Price, Quote, News and Overview

NYSE:CRL - New York Stock Exchange, Inc. - US1598641074 - Common Stock - Currency: USD

161.64  -2 (-1.22%)

After market: 161.64 0 (0%)

CRL Quote, Performance and Key Statistics

CHARLES RIVER LABORATORIES

NYSE:CRL (1/29/2025, 8:15:40 PM)

After market: 161.64 0 (0%)

161.64

-2 (-1.22%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High275
52 Week Low159.65
Market Cap8.27B
Shares51.14M
Float50.64M
Yearly DividendN/A
Dividend YieldN/A
PE15.97
Fwd PE15.62
Earnings (Next)02-12 2025-02-12/amc
IPO06-23 2000-06-23


CRL short term performance overview.The bars show the price performance of CRL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

CRL long term performance overview.The bars show the price performance of CRL in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of CRL is 161.64 USD. In the past month the price decreased by -13.17%. In the past year, price decreased by -25.91%.

CHARLES RIVER LABORATORIES / CRL Daily stock chart

CRL Latest News, Press Releases and Analysis

News Image
14 days ago - Chartmill

Top S&P500 movers in Thursday's session

Top movers analysis one hour before the close of the markets of S&P500 on 2025-01-16: top gainers and losers in today's session.

News Image
14 days ago - Chartmill

Which S&P500 stocks are gapping on Thursday?

Looking for the S&P500 stocks that are experiencing notable gaps on Thursday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.

News Image
14 days ago - Chartmill

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.

CRL Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 26.52 217.35B
DHR DANAHER CORP 29.87 161.60B
A AGILENT TECHNOLOGIES INC 27.81 41.95B
IQV IQVIA HOLDINGS INC 18.24 35.95B
MTD METTLER-TOLEDO INTERNATIONAL 35.01 28.18B
WST WEST PHARMACEUTICAL SERVICES 50.23 24.59B
WAT WATERS CORP 35.48 24.00B
ILMN ILLUMINA INC 76.14 20.89B
ICLR ICON PLC 14.12 16.36B
RVTY REVVITY INC 26.11 15.03B
AVTR AVANTOR INC 21.93 14.63B
TECH BIO-TECHNE CORP 40.13 11.41B

About CRL

Company Profile

CRL logo image Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 20,000 full-time employees. The company went IPO on 2000-06-23. The firm's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Company Info

CHARLES RIVER LABORATORIES

251 Ballardvale St

Wilmington MASSACHUSETTS 01887 US

CEO: James C. Foster

Employees: 21100

Company Website: https://www.criver.com/

Investor Relations: https://ir.criver.com

Phone: 17812226000

CRL FAQ

What is the stock price of CRL?

The current stock price of CRL is 161.64 USD.


What is the symbol for CHARLES RIVER LABORATORIES stock?

The exchange symbol of CHARLES RIVER LABORATORIES is CRL and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is CRL stock listed?

CRL stock is listed on the New York Stock Exchange, Inc. exchange.


Is CRL a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CRL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CRL.


Does CRL stock pay dividends?

CRL does not pay a dividend.


When does CRL stock report earnings?

CRL will report earnings on 2025-02-12, after the market close.


What is the Price/Earnings (PE) ratio of CRL?

The PE ratio for CRL is 15.97. This is based on the reported non-GAAP earnings per share of 10.12 and the current share price of 161.64 USD.


What is the Short Interest ratio of CRL stock?

The outstanding short interest for CRL is 4.46% of its float.


CRL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CRL Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CRL. While CRL belongs to the best of the industry regarding profitability, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CRL Financial Highlights

Over the last trailing twelve months CRL reported a non-GAAP Earnings per Share(EPS) of 10.12. The EPS decreased by -9.4% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.17%
ROA 5.16%
ROE 10.92%
Debt/Equity 0.62
Chartmill High Growth Momentum
EPS Q2Q%-4.78%
Sales Q2Q%-1.64%
EPS 1Y (TTM)-9.4%
Revenue 1Y (TTM)-3.67%

CRL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 67% to CRL. The Buy consensus is the average rating of analysts ratings from 25 analysts.

For the next year, analysts expect an EPS growth of -3.27% and a revenue growth -1.71% for CRL


Ownership
Inst Owners102.9%
Ins Owners0.81%
Short Float %4.46%
Short Ratio3.37
Analysts
Analysts67.2
Price Target220.21 (36.23%)
EPS Next Y-3.27%
Revenue Next Year-1.71%